Paraneoplastic pemphigus

Paraneoplastic pemphigus
Synonyms	Paraneoplastic autoimmune multiorgan syndrome
Pronounce	N/A
Specialty	N/A
Symptoms	Painful mucosal erosions, skin blisters, oral lesions
Complications	Bronchiolitis obliterans, infection, sepsis
Onset	Typically in adulthood
Duration	Chronic
Types	N/A
Causes	Associated with neoplasms such as non-Hodgkin lymphoma, chronic lymphocytic leukemia, Castleman disease, thymoma, sarcoma
Risks	Presence of malignancy
Diagnosis	Clinical examination, biopsy, immunofluorescence
Differential diagnosis	Pemphigus vulgaris, Stevens-Johnson syndrome, toxic epidermal necrolysis
Prevention	N/A
Treatment	Immunosuppressive therapy, corticosteroids, rituximab, plasmapheresis
Medication	N/A
Prognosis	Variable, often poor due to underlying malignancy
Frequency	Rare
Deaths	N/A

Paraneoplastic Pemphigus is a rare, multiorgan autoimmune disease that is associated with malignancies. It is characterized by painful mucosal erosions and polymorphous skin lesions. The disease is often associated with lymphoproliferative disorders such as non-Hodgkin's lymphoma, chronic lymphocytic leukemia, and Castleman's disease.

Etiology

The exact cause of Paraneoplastic Pemphigus is unknown. However, it is believed to be an autoimmune disorder, which means the body's immune system mistakenly attacks healthy cells. In the case of Paraneoplastic Pemphigus, the immune system attacks the skin and mucous membranes.

Symptoms

The symptoms of Paraneoplastic Pemphigus can vary greatly from person to person. However, common symptoms include:

• Painful sores in the mouth and on the lips
• Skin rashes, often on the chest, back, and abdomen
• Blisters on the skin and mucous membranes
• Severe conjunctivitis
• Difficulty swallowing due to sores in the esophagus

Diagnosis

Diagnosis of Paraneoplastic Pemphigus often involves a combination of clinical findings, histopathology, immunofluorescence studies, and serology. A skin biopsy is often performed to confirm the diagnosis.

Treatment

Treatment of Paraneoplastic Pemphigus is primarily aimed at managing the symptoms and treating the underlying malignancy. This may involve the use of corticosteroids, immunosuppressive drugs, and other therapies.

Prognosis

The prognosis for individuals with Paraneoplastic Pemphigus is generally poor, with a high mortality rate. The prognosis is often dependent on the underlying malignancy and the individual's response to treatment.

See Also

• Autoimmune diseases
• Non-Hodgkin's lymphoma
• Chronic lymphocytic leukemia
• Castleman's disease